GAPDH-APOA2 Fusion FISH Probe
The GAPDH-APOA2 Fusion FISH Probe is used to confirm a fusion of the GAPDH and APOA2 genes. The fusion of the GAPDH and APOA2 genes has been associated with Liver Hepatocellular Carcinoma, and Liver Hepatocellular Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| GAPDH-APOA2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| GAPDH-APOA2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| GAPDH-APOA2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| GAPDH-APOA2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| GAPDH-APOA2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| GAPDH-APOA2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| GAPDH-APOA2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| GAPDH-APOA2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| GAPDH-APOA2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| GAPDH-APOA2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| GAPDH-APOA2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| GAPDH-APOA2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| GAPDH-APOA2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| GAPDH-APOA2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| GAPDH-APOA2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| GAPDH-APOA2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| GAPDH-APOA2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| GAPDH-APOA2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| GAPDH-APOA2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| GAPDH-APOA2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| GAPDH-APOA2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| GAPDH-APOA2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| GAPDH-APOA2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| GAPDH-APOA2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| GAPDH-APOA2-20-AQAQ | 20 (40 μL) | 200 μL |
|
APOA2 Gene Summary
This gene encodes apolipoprotein (apo-) A-II, which is the second most abundant protein of the high density lipoprotein particles. The protein is found in plasma as a monomer, homodimer, or heterodimer with apolipoprotein D. Defects in this gene may result in apolipoprotein A-II deficiency or hypercholesterolemia. [provided by RefSeq, Jul 2008]
Gene Name: Apolipoprotein A2
Chromosome: CHR1: 161192082 -161193418
Locus: 1q23.3
GAPDH Gene Summary
This gene encodes a member of the glyceraldehyde-3-phosphate dehydrogenase protein family. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. The product of this gene catalyzes an important energy-yielding step in carbohydrate metabolism, the reversible oxidative phosphorylation of glyceraldehyde-3-phosphate in the presence of inorganic phosphate and nicotinamide adenine dinucleotide (NAD). The encoded protein has additionally been identified to have uracil DNA glycosylase activity in the nucleus. Also, this protein contains a peptide that has antimicrobial activity against E. coli, P. aeruginosa, and C. albicans. Studies of a similar protein in mouse have assigned a variety of additional functions including nitrosylation of nuclear proteins, the regulation of mRNA stability, and acting as a transferrin receptor on the cell surface of macrophage. Many pseudogenes similar to this locus are present in the human genome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2014]
Gene Name: Glyceraldehyde-3-phosphate Dehydrogenase
Chromosome: CHR12: 6643656 -6647536
Locus: 12p13.31
Gene Diseases
The GAPDH APOA2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Liver Hepatocellular Carcinoma |
| Liver Hepatocellular Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|